{
  "Disease": [
    {"role": "user", "content": "Please identify the \"Disease\" entities in the following paragraph. Please present the valid entities as a Markdown table with one column \"Disease\". Make sure to present the entities precisely in the same words as in the original paragraph.\n\nParagraph: Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1 .\n\nLet's think step by step."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Human MLH1 deficiency |\n| Hematological malignancy |\n| Neurofibromatosis type 1 |"},
    {"role": "user", "content": "Please remove entities that do not clearly refer to \"Disease\" and present the valid entities as a Markdown table with one column \"Disease\".\n\nMake sure to present the entities precisely in the same words as in the original paragraph."},
    {"role": "assistant", "content": "| Disease |\n| --- |\n| Human MLH1 deficiency |\n| Hematological malignancy |\n| Neurofibromatosis type 1 |\n\nExplanation:\n\n* Human MLH1 deficiency is a genetic condition. However, it is classified as a disease because it increases the risk of other diseases (hematological malignancy and neurofibromatosis type 1).\n* Hematological malignancy is a broad category of diseases that affect the blood, bone marrow, or lymphatic system.\n* Neurofibromatosis type 1 is a nervous system disorder characterized by the growth of benign tumors on nerves. It is considered a disease because it causes various health problems and complications."}
  ]
}